Fecal Microbiota Transplantation in Postoperative Crohn's Disease
NCT ID: NCT04637438
Last Updated: 2022-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2021-05-18
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FMT for Postop Crohn's Disease
NCT05248191
Fecal Transplant for Crohn's Disease
NCT03078803
Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
NCT01961492
Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease
NCT02199561
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fecal Microbiota Transplantation
Fecal Microbiota Transplantation
FMT via colonoscopy
Plasebo
Placebo
Water infusion via colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fecal Microbiota Transplantation
FMT via colonoscopy
Placebo
Water infusion via colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide written consent
* Stricturing and/or fistulizing Crohn's disease needing ileocecal or ileal resection
Exclusion Criteria
* Active infection, abscess or fistula at the time of the first colonoscopy
* Life expectancy \<1 year
* Unable to provide written consent
* Use on antibiotics or probiotics at the time of first colonoscopy
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turku University Hospital
OTHER_GOV
Joint Authority for Päijät-Häme Social and Health Care
OTHER
Kuopio University Hospital
OTHER
Helsinki University Central Hospital
OTHER
Tampere University
OTHER
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elina Jokinen
Doctor of Medical Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R20041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.